Cargando…

MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas

OBJECTIVES: To assess the combined role of tumor vascularity, estimated from perfusion MRI, and MGMT methylation status on overall survival (OS) in patients with glioblastoma. METHODS: A multicentric international dataset including 96 patients from NCT03439332 clinical study were used to study the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuster-Garcia, Elies, Lorente Estellés, David, Álvarez-Torres, María del Mar, Juan-Albarracín, Javier, Chelebian, Eduard, Rovira, Alex, Acosta, Cristina Auger, Pineda, Jose, Oleaga, Laura, Mollá-Olmos, Enrique, Filice, Silvano, Due-Tønnessen, Paulina, Meling, Torstein R., Emblem, Kyrre E., García-Gómez, Juan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880975/ https://www.ncbi.nlm.nih.gov/pubmed/33001310 http://dx.doi.org/10.1007/s00330-020-07297-4

Ejemplares similares

Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype
por: Chelebian, Eduard, et al.
Publicado: (2020)

Interpreting deep learning models for glioma survival classification using visualization and textual explanations
por: Osadebey, Michael, et al.
Publicado: (2023)

Towards patient-specific modeling of brain tumor growth and formation of secondary nodes guided by DTI-MRI
por: Angeli, Stelios, et al.
Publicado: (2018)

Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT
por: Álvarez-Torres, María del Mar, et al.
Publicado: (2021)

Quantification of Tissue Compression Identifies High-Grade Glioma Patients with Reduced Survival
por: Fuster-Garcia, Elies, et al.
Publicado: (2022)

A theoretical framework for determining cerebral vascular function and heterogeneity from dynamic susceptibility contrast MRI
por: Digernes, Ingrid, et al.
Publicado: (2017)

Genomic characterization of ependymomas reveals 6q loss as the most common aberration
por: OLSEN, THALE KRISTIN, et al.
Publicado: (2014)

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
por: Håvik, Annette Bentsen, et al.
Publicado: (2012)

Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification
por: Juan-Albarracín, Javier, et al.
Publicado: (2015)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
por: Due-Tønnessen, Paulina, et al.
Publicado: (2019)

Author Correction: The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
por: Due-Tønnessen, Paulina, et al.
Publicado: (2021)

Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification
por: Álvarez-Torres, María del Mar, et al.
Publicado: (2022)

MR elastography identifies regions of extracellular matrix reorganization associated with shorter survival in glioblastoma patients
por: Svensson, Siri Fløgstad, et al.
Publicado: (2023)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

The impact of surgical simulation on patient outcomes: a systematic review and meta-analysis
por: Meling, Trym R., et al.
Publicado: (2020)

President's address EANS2023
por: Meling, Torstein R.
Publicado: (2023)

Postoperative radiotherapy for pediatric brain tumor: a lesson learned from treatment of a 5-year-old girl for posterior fossa astrocytoma (WHO1) in 1967
por: Lundar, Tryggve, et al.
Publicado: (2018)

Posterior fossa ependymoma in childhood: 60 years event-free survival after partial resection—a case report
por: Lundar, Tryggve, et al.
Publicado: (2015)

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
por: van Nifterik, K A, et al.
Publicado: (2010)

MGMT promoter methylation in Peruvian patients with glioblastoma
por: Belmar-Lopez, Carolina, et al.
Publicado: (2018)

Benefits of clinical criteria and high-throughput sequencing for diagnosing children with syndromic craniosynostosis
por: Tønne, Elin, et al.
Publicado: (2020)

The role of EC-IC bypass in ICA blood blister aneurysms—a systematic review
por: Meling, Torstein R., et al.
Publicado: (2020)

Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM
por: Shah, Nameeta, et al.
Publicado: (2011)

A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT
por: Raghavan, Sudhir, et al.
Publicado: (2020)

Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients
por: Lundar, Tryggve, et al.
Publicado: (2020)

Evaluation of Memorial Sloan‐Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma
por: Jahr, Guro, et al.
Publicado: (2018)

How I do it: the trans-laminar, facet-joint sparing minimal invasive approach for ventral dural repair in spontaneous intracranial hypotension—a 2-dimensional operative video
por: Corniola, Marco V., et al.
Publicado: (2021)

How I do it: minimally invasive resection of a sub-ependymoma of the fourth ventricle
por: Corniola, Marco V., et al.
Publicado: (2020)

Management of Recurrent Meningiomas: State of the Art and Perspectives
por: Corniola, Marco Vincenzo, et al.
Publicado: (2022)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
por: Melguizo, Consolación, et al.
Publicado: (2012)

Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy
por: Due-Tønnessen, Bernt Johan, et al.
Publicado: (2015)

Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients
por: Lundar, Tryggve, et al.
Publicado: (2015)

A 34-Year-Old Woman with Brainstem Cavernous Malformation: The Anterior Transcallosal Transchoroidal Approach and Literature Review
por: Hosainey, Sayied Abdol Mohieb, et al.
Publicado: (2014)

How I do it: retrosigmoid intradural inframeatal petrosectomy
por: Meling, Torstein R., et al.
Publicado: (2020)

Natural history and treatment options of radiation-induced brain cavernomas: a systematic review
por: Patet, Gildas, et al.
Publicado: (2021)

Homogeneous MGMT Immunoreactivity Correlates with an Unmethylated MGMT Promoter Status in Brain Metastases of Various Solid Tumors
por: Ingold, Barbara, et al.
Publicado: (2009)

Outcomes in adulthood after neurosurgical treatment of brain tumors in the first 3 years of life: long-term follow-up of a single consecutive institutional series of 97 patients
por: Lundar, Tryggve, et al.
Publicado: (2021)

Inducing Biomechanical Heterogeneity in Brain Tumor Modeling by MR Elastography: Effects on Tumor Growth, Vascular Density and Delivery of Therapeutics
por: Harkos, Constantinos, et al.
Publicado: (2022)

MGMT Promoter Methylation and Parathyroid Carcinoma
por: Storvall, Sara, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4be7978m1j9ktt51o85daii89p